Diabetic Investor: MannKind is a Disaster Waiting To Happen
"Diabetic Investor has tried to warn everyone that MannKind is nothing more than a disaster waiting to happen. It would be wiser to invest in lottery tickets than shares of MannKind. Yet just as there are baseball fans who believe the Chicago Cubs will win the World Series in the next century or so, there are also investors who believe in the inhaled insulin myth. As a good friend of Diabetic Investor likes to say, there is no cure for stupid." ---- Adam Feuerstein
Inhalation is just the delivery method, most would prefer this to injection, some may not, either way this isn't the most important thing.... Afrezza is a far superior drug to anything on the market currently, and as it appears now, anything that will be coming to the market in the next couple years at least (in fact there is an extremely slim margin for any drug to EVER out-perform Afrezza because it so closely mimics an actual healthy human pancreas and slim to no side effects). I'll give you an "E" for effort, better leave this one to the pros though son.